{"id":13858,"date":"2021-04-09T13:33:18","date_gmt":"2021-04-09T13:33:18","guid":{"rendered":"https:\/\/www.profactor.at\/research\/additive-micronano-manufacturing\/additive-inkjet-printing\/projects\/inkplant-ec-h2020\/"},"modified":"2023-08-08T15:09:08","modified_gmt":"2023-08-08T14:09:08","slug":"inkplant-ec-h2020","status":"publish","type":"page","link":"https:\/\/www.profactor.at\/en\/research\/additive-micro-and-nano-manufacturing\/multimaterial-inkjet-printing\/projects\/inkplant-ec-h2020\/","title":{"rendered":"INKplant (EC-H2020)"},"content":{"rendered":"

[vc_row][vc_column width=”3\/4″][vc_column_text]

<\/div>
<\/div><\/div>[\/vc_column_text][vc_column_text el_class=”overview-description”]<\/p>\n

INKplant prints the future of regenerative medicine to face the ageing of the European population<\/h3>\n

\u00a0<\/strong><\/p>\n

PROFACTOR coordinates ambitious EC project INKplant with nineteen partners from universities, research centers, SMEs, multinational corporations, and hospitals. Since January 2021 a multidisciplinary team working on the fusion of different biomaterials and 3D printing technologies aims to bring a new solution to the fabrication of biomimetic implants.<\/strong><\/em><\/p>\n

 <\/p>\n

The ageing of the population is one of the great challenges of Europe in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic defects of the joints or defects in the oral and maxillofacial region have a significantly reduced quality of life and are continuously dependent on healthcare. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent, risk-group patients can become. Therefore, science and technology must walk together to ensure that living longer can be synonymous with living well. INKplant, European Union’s H2020 funded project<\/strong>, was conceived to face this challenge and democratize its new solutions.<\/em><\/p>\n

 <\/p>\n

An ambitious initiative with a 6 million euro budget that will create patient-specific implants by combining different advanced biomaterials and state-of-the-art technologies. This would be possible thanks to high-resolution additive manufacturing technologies (lithographic ceramic manufacturing and 3D multi-material inkjet printing) and advanced simulation and biological evaluation. The resultant implants will conform to each patient like a tailor-made suit.<\/p>\n

 <\/p>\n

Reducing healthcare costs and rehabilitation time<\/h3>\n

\u00a0<\/strong>The INKplant approach could significantly reduce or even avoid the need for invasive surgical procedures using inorganic prosthetic components<\/strong>. The methods envisaged in the project represent an enormous improvement in the quality of life of the patients and will reduce the invasivity as well as the complications arising from prosthetic components by improving the biocompatibility of the materials used.
\nINKplant will provide new solutions to some of the most widespread and urgent medical problems in European healthcare. The project partners will work on four different use cases: defects of meniscus, osteochondral defects, palatal defects, and patient-specific implants for dental and oral rehabilitation.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n